26 years of experience
Injection medicine only of CAR-T therapy (Yikeda® Axicabtagene Ciloleucel Injection).
Shanghai Tongji Hospital has performed 1,500+ CAR-T infusions, making it one of the most experienced centers globally. The program started in 2014 and follows a standardized pathway for cell preparation and patient monitoring. As a tertiary university-affiliated hospital, it uses advanced immunophenotyping to determine eligibility for therapy. A multidisciplinary tumor board including hematology and pathology specialists plans each case. This international department offers personalized bridging therapy and long-term follow-up care for high-risk refractory cases.